Cannabidiol Safety In Question At US FDA? Exploding Market Suggests Not So Much
A report FDA submitted to Congress earlier in March on determining an enforcement discretion policy for CBD-containing non-drug products did little to indicate it is approaching a decision. It's likely that FDA officials are reasonably confident of CBD's safety in food and supplements because the agency has allowed the market to proliferate.
You may also be interested in...
"It's a great industry to be in with it being pandemic proof," says Natural Marketing Institute managing partner Steve French. "Consumers really want one-stop shopping in this situation. They want stores they can get into and get out of it," says IRI health care executive Kristin Hornberger.
UK advertising regulator says an ad catalog retailer claiming a CBD patch could reduce chronic pain, anxiety and diabetes violated advertising codes. The agency says claims including the product penetrated quickly through skin were medicinal and not approved by the UK or EU.
In report to Congress about determining an enforcement discretion policy for CBD-containing non-drug products, FDA described challenges it faces, largely unique in its history, in determining whether hemp-derived ingredients are safe in food, supplements and other products that already are “sold increasingly widely."